A citation-based method for searching scientific literature

Uri Elkayam, Mohammed Waseem Akhter, Priya Tummala, Salman Khan, Harpreet Singh. J Cardiovasc Pharmacol Ther 2002
Times Cited: 27







List of co-cited articles
206 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Reduced oxygen tension increases atrial natriuretic peptide release from atrial cardiocytes.
J R Klinger, L Pietras, R Warburton, N S Hill. Exp Biol Med (Maywood) 2001
20
10


Distinct and specific functions of cGMP-dependent protein kinases.
S M Lohmann, A B Vaandrager, A Smolenski, U Walter, H R De Jonge. Trends Biochem Sci 1997
320
7

Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
P J Hunt, E A Espiner, M G Nicholls, A M Richards, T G Yandle. J Clin Endocrinol Metab 1996
67
7


Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.
A Lerman, R J Gibbons, R J Rodeheffer, K R Bailey, L J McKinley, D M Heublein, J C Burnett. Lancet 1993
291
7

Natriuretic peptides and acute renal failure.
David L Vesely. Am J Physiol Renal Physiol 2003
84
7

Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage.
E Berendes, M Walter, P Cullen, T Prien, H Van Aken, J Horsthemke, M Schulte, K von Wild, R Scherer. Lancet 1997
263
7


Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay.
Kiang-Teck J Yeo, Alan H B Wu, Fred S Apple, Martin H Kroll, Robert H Christenson, Kent B Lewandrowski, Frank A Sedor, Anthony W Butch. Clin Chim Acta 2003
241
7

Brain natriuretic peptide-like immunoreactivity is present in human plasma.
K Togashi, Y Hirata, K Ando, Y Takei, M Kawakami, F Marumo. FEBS Lett 1989
38
7





Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.
K Hasegawa, H Fujiwara, K Doyama, M Miyamae, T Fujiwara, S Suga, M Mukoyama, K Nakao, H Imura, S Sasayama. Circulation 1993
184
7



Guanylyl cyclase receptors.
D L Garbers, D G Lowe. J Biol Chem 1994
244
7

Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction.
A S Maisel, J Koon, P Krishnaswamy, R Kazenegra, P Clopton, N Gardetto, R Morrisey, A Garcia, A Chiu, A De Maria. Am Heart J 2001
291
7

Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction.
F Muders, E P Kromer, D P Griese, M Pfeifer, H W Hense, G A Riegger, D Elsner. Am Heart J 1997
108
7


Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide.
M Suda, Y Ogawa, K Tanaka, N Tamura, A Yasoda, T Takigawa, M Uehira, H Nishimoto, H Itoh, Y Saito,[...]. Proc Natl Acad Sci U S A 1998
132
7

Plasma brain natriuretic peptide concentration: impact of age and gender.
Margaret M Redfield, Richard J Rodeheffer, Steven J Jacobsen, Douglas W Mahoney, Kent R Bailey, John C Burnett. J Am Coll Cardiol 2002
821
7

Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes.
Faye Wu, Wei Yan, Junliang Pan, John Morser, Qingyu Wu. J Biol Chem 2002
123
7

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
A M Richards, M G Nicholls, T G Yandle, C Frampton, E A Espiner, J G Turner, R C Buttimore, J G Lainchbury, J M Elliott, H Ikram,[...]. Circulation 1998
562
7


Atrial natriuretic factor attenuates the pulmonary pressor response to hypoxia.
S Adnot, P E Chabrier, C Brun-Buisson, I Viossat, P Braquet. J Appl Physiol (1985) 1988
105
7


B-type natriuretic peptides: a diagnostic breakthrough for clinicians.
Peter A McCullough, Torbjørn Omland, Alan S Maisel. Rev Cardiovasc Med 2003
129
7



A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation.
Stacey J Wieczorek, Alan H B Wu, Robert Christenson, Padma Krishnaswamy, Stephen Gottlieb, Thomas Rosano, David Hager, Nancy Gardetto, Albert Chiu, Kathryn R Bailly,[...]. Am Heart J 2002
141
7



Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.
P J Hunt, A M Richards, M G Nicholls, T G Yandle, R N Doughty, E A Espiner. Clin Endocrinol (Oxf) 1997
440
7

B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study.
Peter A McCullough, Richard M Nowak, James McCord, Judd E Hollander, Howard C Herrmann, Philippe G Steg, Philippe Duc, Arne Westheim, Torbjørn Omland, Cathrine Wold Knudsen,[...]. Circulation 2002
662
7

Signal transduction by guanylyl cyclases.
M Chinkers, D L Garbers. Annu Rev Biochem 1991
217
7

Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length.
S Wiese, T Breyer, A Dragu, R Wakili, T Burkard, S Schmidt-Schweda, E M Füchtbauer, U Dohrmann, F Beyersdorf, D Radicke,[...]. Circulation 2000
185
7



Natriuretic peptides in patients with aortic stenosis.
W Qi, P Mathisen, J Kjekshus, S Simonsen, R Bjørnerheim, K Endresen, C Hall. Am Heart J 2001
126
7


Plasma human brain natriuretic peptide in chronic renal failure.
T Akiba, K Tachibana, K Togashi, M Hiroe, F Marumo. Clin Nephrol 1995
64
7

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
F Follath, J G F Cleland, H Just, J G Y Papp, H Scholz, K Peuhkurinen, V P Harjola, V Mitrovic, M Abdalla, E-P Sandell,[...]. Lancet 2002
733
7

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
Michael S Cuffe, Robert M Califf, Kirkwood F Adams, Raymond Benza, Robert Bourge, Wilson S Colucci, Barry M Massie, Christopher M O'Connor, Ileana Pina, Rebecca Quigg,[...]. JAMA 2002
772
7

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
M Packer, J R Carver, R J Rodeheffer, R J Ivanhoe, R DiBianco, S M Zeldis, G H Hendrix, W J Bommer, U Elkayam, M L Kukin. N Engl J Med 1991
7

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
Mihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor, Kirkwood F Adams, Uri Elkayam, Alejandro Barbagelata, Jalal K Ghali, Raymond L Benza, Frank A McGrew, Marc Klapholz,[...]. JAMA 2004
517
7

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Mihai Gheorghiade, Imran Niazi, John Ouyang, Frank Czerwiec, Jun-ichi Kambayashi, Manuela Zampino, Cesare Orlandi. Circulation 2003
343
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.